Investor Relations

Investor Relations

Latest News View All News

Jun 12, 2019 • 4:05 PM EDT

Cerecor Appoints Keith Schmidt to its Board of Directors

Jun 11, 2019 • 1:00 PM EDT

Cerecor Set to Join Russell 3000® Index

May 9, 2019 • 4:05 PM EDT

Cerecor Reports First Quarter 2019 Results

Stock Information View Detailed Stock Information

Nasdaq: CERC Cerecor, Inc.
Price
Change
Volume
Day Range
52 Week Range

Company Overview

Cerecor is an integrated biopharmaceutical company developing innovative therapies at the cutting edge of science. Our pipeline, filled with forward-thinking ideas, propels us forward. We are driven to change the lives of patients with rare orphan diseases in Pediatrics and Neurology.